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Background & Hypothesis:
Disorders in blood coagulation may play a role in peripheral artery disease. The aim of this study was 
to investigate the association between functional polymorphism C677T (rs1801133) of 
methylenetetrahydrofolate reductase (MTHFR) gene for and risk of peripheral artery disease in 
diabetes patients.
Methods:
The study sample included 434 unrelated Russian patients (50 patients with diabetic angiopathy of 
lower limbs and 384 healthy subjects). Genotyping of the polymorphism was performed by TaqMan 
assay.
Results:
No statistically significant differences in frequencies of the MTHFR alleles and genotypes were found 
between the study groups, as between entire groups as well as between gender stratified groups (P 
>0.05). However, we found that the 677TT genotype showed an association with increased risk of the 
disease in male smokers (OR = 4.2 95% CI 1.28-13.79, P = 0.01), whereas non-smoker carriers of the 
677TT genotype did not exert the disease risk.
Discussion & Conclusion:
Thus, increased risk of peripheral artery disease (diabetic angiopathy) is attributed to the interaction 
between the MTHFR gene polymorphism and tobacco smoking, pointing out to an importance of 
gene-environment interactions in disease susceptibility. We suggest that disease risk in patients with 
"thrombotic genotype" of the MTHFR gene is triggered by tobacco smoking exposure. The study was 
supported by the Russian Research Foundation (No.-15-15-10010).
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